Nicholas Moore
- Toxicology top 0.02%
- Pharmacovigilance and Adverse Drug Reactions 59
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes 28
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 37
- Drug-Induced Hepatotoxicity and Protection 26
- Drug-Induced Adverse Reactions 25
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 37
- Drug-Induced Hepatotoxicity and Protection 26
- Drug-Induced Adverse Reactions 25
-
- Health Systems, Economic Evaluations, Quality of Life 21
-
- Atrial Fibrillation Management and Outcomes 19
- Antiplatelet Therapy and Cardiovascular Diseases 19
Nicholas Moore
397 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 197
- Toxicology 1.7k
- Geriatrics and Gerontology 919
- Experimental and Cognitive Psychology 1.9k
- Pharmacology 2.1k
- Pharmacology 861
Countries citing papers authored by Nicholas Moore
This map shows the geographic impact of Nicholas Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Moore more than expected).
Fields of papers citing papers by Nicholas Moore
This network shows the impact of papers produced by Nicholas Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Moore. The network helps show where Nicholas Moore may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicholas Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 26 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 27 | |
| 6 | 2017 | 1 | |
| 7 | 2017 | 5 | |
| 8 | 2013 | 7 | |
| 9 | 2013 | 4 | |
| 10 | 2012 | 21 | |
| 11 | 2012 | 59 | |
| 12 | 2011 | 1 | |
| 13 | 2008 | 19 | |
| 14 | 2008 | 10 | |
| 15 | 2007 | 69 | |
| 16 | [Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells]. | 2007 | 6 |
| 17 | 2006 | 468 | |
| 18 | 2006 | 13 | |
| 19 | Guidelines on evaluation of treatment of alcohol dependence | 1994 | 28 |
| 20 | [A microcomputer databank of hepatotoxic drugs]. | 1986 | 1 |
About Nicholas Moore
Nicholas Moore is a scholar working on Toxicology, Geriatrics and Gerontology and Pharmacology, having authored 411 papers that have together received 13.3k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (59 papers), Inflammatory mediators and NSAID effects (37 papers), Pharmaceutical Practices and Patient Outcomes (28 papers), Drug-Induced Hepatotoxicity and Protection (26 papers), Drug-Induced Adverse Reactions (25 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (19 papers). The work is most often cited by research in Toxicology (1.7k citations), Geriatrics and Gerontology (919 citations) and Experimental and Cognitive Psychology (1.9k citations). Nicholas Moore has collaborated with scholars based in France, Belize and China. Frequent co-authors include Alexandre Pariente, Mathiéu Molimard, Pierre Philip, Patricia Sagaspe, Annie Fourrier‐Réglat, Bernard Bégaud, R. Lassalle, Patrick Blin, Jacques Taillard and Bernard Bioulac. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Drug Safety, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.